Other
Plantar Wart
18
Pipeline Programs↗
6
Active Trials↗
6
Companies Involved↗
Plantar Wart is an emerging landscape with 18 programs across 6 companies. The most active players are Aurobindo Pharma Ltd, Nowarta Biopharma Inc, Pfizer. 5 therapies are approved with 4 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical6
Phase 34
Analysis
Trial Status
20
clinical trials
Unknown status9 · 45%
Recruiting3 · 15%
Completed3 · 15%
Not yet recruiting2 · 10%
Terminated1 · 5%
Withdrawn1 · 5%
Other1 · 5%
Clinical Trials
Trial Activity
20 trials
A Self-controlled Study of Bleomycin and Pingyangmycin Injection in the Treatment of Plantar Warts
Active, not recruiting·SSecond Affiliated Hospital, School of Medicine, Zhejiang University·Approved·NCT07197541·200 enrolled
Intralesional Vitamin D Versus Intralesional Acyclovir in Plantar Warts
Not yet recruiting·—·Phase 4·NCT07196670·60 enrolled
Microneedling Alone Versus Microneedling Coupled With Either Bleomycin or 5flourouracil in the Treatment of Plantar Warts
Not yet recruiting·—·N/A·NCT07041749·60 enrolled
Studying of Natural Constituents' Treatment of Plantar Warts
Completed·—·Phase 1·NCT05592041·20 enrolled
Intralesional Acyclovir Versus Cryotherapy in the Treatment of Plantar Warts. A Randomized Controlled Trial.
Unknown status·—·Phase 2/3·NCT06261684·92 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)